Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net income (loss) $ (62,908) $ 140,335
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization 117,844 106,252
Impairment expense 16,654 0
Deferred income tax expense (benefit) (15,490) 42,623
Amortization of deferred debt issuance costs 407 405
Stock-based compensation 5,968 5,246
Provision for credit losses 448 475
Loss on disposal of assets 39,875 81,578
Changes in operating assets and liabilities:    
Accounts receivable 117,072 (73,268)
Other current assets 2,598 603
Inventories 587 4,503
Prepaid expenses 4,741 1,973
Accounts payable (97,380) (11,496)
Accrued and other current liabilities (11,996) 8,042
Accrued interest (394) 358
Net cash provided by operating activities 118,026 307,629
CASH FLOWS FROM INVESTING ACTIVITIES:    
Capital expenditures (86,509) (394,343)
Proceeds from sale of assets 4,330 6,774
Net cash used in investing activities (82,179) (387,569)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from borrowings 0 110,000
Repayments of borrowings (130,000) (50,000)
Payment of finance lease obligation (30) (186)
Repayments of insurance financing 0 (4,547)
Proceeds from exercise of equity awards 0 1,164
Tax withholdings paid for net settlement of equity awards (598) 0
Net cash provided by (used in) financing activities (130,628) 56,431
NET DECREASE IN CASH AND CASH EQUIVALENTS (94,781) (23,509)
CASH AND CASH EQUIVALENTS - Beginning of period 149,036 132,700
CASH AND CASH EQUIVALENTS - End of period $ 54,255 $ 109,191